BioVentureHub BuzzBy Jamie Smith - 30 Jun 2017
Happy Friday! Here’s the latest buzz from the AZ BioVentureHub…
Athera completes multiple dosing trial with its fully human antibody PC-mAb
Cereno Scientific receives grants for development of CS1
Corline has signed a letter of intent with Oxford University regarding clinical studies in diabetes type 1
InOrbit Therapeutics have moved in!
i-Tech - Stena RoRo selects Selektope® for extensive newbuild program
i-Tech - a new antifouling product containing the bio-repellent ingredient Selektope® has been launched.
Mölnlycke is moving in!
NanoSIMS - check out the growing list of NanoSIMS/mass spectrometry publications produced by Per and his team
Tataa has launched GrandPerformance assays for expression profiling of single circulating tumor cells
Vicore Pharma is growing and making strategic recruitments
A BIG THANK YOU to Antaros, Athera, Corline, Promimic and Q&Q Labs for participating in the full day media visit from Göteborgs-Posten that we hosted this week.
Look out for a feature article in GP in August!
Have a great weekend!